Иммунотерапия и CAR-T

Эксперты TIME назвали вакцины и иммунотерапию перспективными в борьбе с раком

Эксперты TIME назвали вакцины и иммунотерапию перспективными в борьбе с раком UA.NEWS

Novel immunotherapy leads to complete regression of chemotherapy-resistant liver cancer in 3-year-old

A new report in the New England Journal of Medicine by researchers at Baylor College of Medicine, Texas Children's Hospital and Seattle Children's describes a complete regression of hepatoblastoma, the most common pediatric liver cancer, in a 3-year-old treated with a novel immunotherapy.

Mitochondrial RNA escape may explain how chronic immune signaling helps tumors grow

Cancer biology—and, in turn, cancer treatment—have come a long way in the last few decades. Most people recognize this progress in breakthroughs like immunotherapy, a treatment strategy first deployed in 2011 that leverages the body's own immune cells to fight cancer. It has revolutionized the treatment landscape…

Targeting CDK2 Could Boost Immunotherapy Response in Patients With a Wide Range of Cancers

Targeting CDK2 Could Boost Immunotherapy Response in Patients With a Wide Range of Cancers Cancer Health

Perioperative immunotherapy as a new standard treatment option

Perioperative immunotherapy as a new standard treatment option VHIO

Vitamin A metabolite keeps immune cells active against recurrent brain tumors

Immune cells can become exhausted after prolonged exposure to cancer, gradually losing their ability to attack tumor cells. This phenomenon is particularly pronounced in aggressive brain tumors and can severely limit the effectiveness of immunotherapy.

BrainChild Bio raises over $100 million to treat kids’ cancers with CAR-Ts

BrainChild Bio raises over $100 million to treat kids’ cancers with CAR-Ts C&EN

Immunotherapy Access Expanded Following Epworth Trial

Immunotherapy Access Expanded Following Epworth Trial Mirage News

Expanding Blood Cancer Care With the Next Frontier of T-Cell Immunotherapy

Expanding Blood Cancer Care With the Next Frontier of T-Cell Immunotherapy targetedonc.com

Real-World Evidence and Meta-Analysis of Chemoimmunotherapy Utilization

Fact-Check Rahul Dua’s Cancer Claims: Immunotherapy Isn’t Always Better, ‘Superfoods’ Don’t Cure

Fact-Check Rahul Dua’s Cancer Claims: Immunotherapy Isn’t Always Better, ‘Superfoods’ Don’t Cure Health and Me

Clatterbridge becomes first in UK to trial new cancer immunotherapy

Clatterbridge becomes first in UK to trial new cancer immunotherapy Wirral Globe

Moderna widens mRNA cancer push with solo vaccine and in vivo CAR-T; Korea trials advance - CHOSUNBIZ

Moderna widens mRNA cancer push with solo vaccine and in vivo CAR-T; Korea trials advance - CHOSUNBIZ Chosunbiz

MCell: блокировка белка CDK2 делает устойчивые к иммунотерапии опухоли уязвимей – ОСН

MCell: блокировка белка CDK2 делает устойчивые к иммунотерапии опухоли уязвимей – ОСН Общественная служба новостей

MCell: блокировка белка CDK2 делает устойчивые к иммунотерапии опухоли уязвимей

MCell: блокировка белка CDK2 делает устойчивые к иммунотерапии опухоли уязвимей Общественная служба новостей